Alberta Investment Management Corp Invests $5.45 Million in Cardinal Health, Inc. $CAH

Alberta Investment Management Corp purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 26,500 shares of the company’s stock, valued at approximately $5,446,000.

A number of other institutional investors and hedge funds have also bought and sold shares of CAH. Integrated Wealth Concepts LLC lifted its position in shares of Cardinal Health by 6.9% during the first quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock valued at $601,000 after purchasing an additional 280 shares in the last quarter. Jones Financial Companies Lllp grew its stake in Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares during the period. Arrowstreet Capital Limited Partnership bought a new position in Cardinal Health in the 2nd quarter valued at $1,935,000. Cerity Partners LLC increased its position in shares of Cardinal Health by 17.0% during the 2nd quarter. Cerity Partners LLC now owns 40,426 shares of the company’s stock valued at $6,792,000 after purchasing an additional 5,880 shares during the last quarter. Finally, Nebula Research & Development LLC grew its position in Cardinal Health by 34.4% during the second quarter. Nebula Research & Development LLC now owns 10,334 shares of the company’s stock valued at $1,736,000 after buying an additional 2,646 shares during the period. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Performance

Shares of NYSE CAH opened at $227.63 on Wednesday. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $233.60. The stock has a market cap of $53.31 billion, a PE ratio of 34.81, a price-to-earnings-growth ratio of 1.24 and a beta of 0.52. The stock has a fifty day moving average of $203.74 and a 200-day moving average of $209.02.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. During the same quarter in the prior year, the firm posted $2.35 EPS. The firm’s quarterly revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, sell-side analysts predict that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be issued a $0.5158 dividend. This represents a $2.06 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Wednesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s payout ratio is 31.19%.

Analyst Upgrades and Downgrades

Several analysts have commented on CAH shares. Citigroup lowered their price objective on shares of Cardinal Health from $249.00 to $245.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Zacks Research downgraded shares of Cardinal Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 12th. JPMorgan Chase & Co. reduced their price objective on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a report on Monday, May 4th. Barclays raised their target price on Cardinal Health from $243.00 to $258.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 24th. Finally, Wells Fargo & Company decreased their price objective on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Fourteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $246.93.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.